Multiple BRD9-binding sites reside within MYC enhancer elements [33,37], with various multiprotein complexes differentially regulating apoptosis outcomes in CRC and other malignancies [33,38,39,40]. The gene discussed is BRD9; the disease is colorectal carcinoma.